Why the study?
Does methyldopa impair psychometric performance in patients with mild to moderate hypertension?
Does methyldopa impair psychometric performance in patients with mild to moderate hypertension?
Short-term methyldopa therapy for hypertension impairs cognitive and psychometric performance, though assessments are heavily confounded by practice effects in crossover designs.
Answers are grounded in this paper and cite their sources.
Methyldopa may impair select cognitive tasks in hypertension; confirms central effects on card-sorting and symbol substitution while highlighting practice-effect confounds in crossover trials.
Double-blind, crossover comparisons of methyldopa with placebo were performed in 16 patients with mild to moderate hypertension. Methyldopa (250 mg tid) for 14 days significantly reduced blood pressure, impaired card-sorting time and digital symbol substitution score, and caused trends for impairment of other psychometric tests. Effects of practice were greater than those of treatment on all tests other than card sorting, although no interaction between treatment and practice was seen. Continued dosage impairs psychometric performance, but practice effect is a major confounder. Simple crossover studies are inadequate for detecting moderate drug effects on intellectual performance.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: